Interpreting networks in systems biology

Clinical Pharmacology and Therapeutics

Volumn 93, Issue 5, 2013, Pages 389-392

  Arrell, D K ^a,b   Terzic, A ^a,b  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEOME;

ARTICLE; BIOMEDICINE; DECISION SUPPORT SYSTEM; FOLLOW UP; MOLECULAR DYNAMICS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; SYSTEMS BIOLOGY;

DECISION SUPPORT TECHNIQUES; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; METABOLIC NETWORKS AND PATHWAYS; SYSTEMS BIOLOGY;

EID: 84876691228     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2013.28     Document Type: Article

References (5)

1. Arrell, D.K. & Terzic, A. Network systems biology for drug discovery. Clin. Pharmacol. Ther. 88, 120-125 (2010).
2. Silverman, E.K. & Loscalzo, J. Developing new drug treatments in the era of network medicine. Clin. Pharmacol. Ther. 93, 26-28 (2013).
3. Arrell, D.K. & Terzic, A. Systems proteomics for translational network medicine. Circ. Cardiovasc. Genet. 5, 478 (2012).
4. Arrell, D.K., Niederländer, N.J., Faustino, R.S., Behfar, A. & Terzic, A. Cardioinductive network guiding stem cell diferentiation revealed by proteomic cartography of tumor necrosis factor alpha-primed endodermal secretome. Stem Cells 26, 387-400 (2008).
5. + channel knockout induces cardiac proteome remodeling predictive of heart disease susceptibility. J. Proteome Res. 8, 4823-4834 (2009).